Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Flavia V Castelino

Showing results (21-30 of 50) with videos related to

Pageof 5
Sort By:
Seminars in Arthritis and Rheumatism|February 20, 2022
Change in calcinosis over 1 year using the scleroderma clinical trials consortium radiologic scoring system for calcinosis of the hands in patients with systemic sclerosisAntonia Valenzuela, Kathryn Stevens, Melody P Chung, et al.
Arthritis Care & Research|February 25, 2015
Barriers to and Facilitators of a Career as a Physician-Scientist Among Rheumatologists in the USAlexis Ogdie, Ami A Shah, Una E Makris, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|March 24, 2016
Autotaxin activity increases locally following lung injury, but is not required for pulmonary lysophosphatidic acid production or fibrosisKatharine E Black, Evgeny Berdyshev, Gretchen Bain, et al.
The Journal of Allergy and Clinical Immunology|March 15, 2016
Clonal expansion of CD4(+) cytotoxic T lymphocytes in patients with IgG4-related diseaseHamid Mattoo, Vinay S Mahajan, Takashi Maehara, et al.
Rheumatology (Oxford, England)|March 15, 2025
Belumosudil in diffuse cutaneous systemic sclerosis: a randomised, double-blind, open-label extension, placebo-controlled, Phase 2 studyLorinda Chung, Richard M Silver, Virginia Steen, et al.
Seminars in Arthritis and Rheumatism|September 8, 2020
Calcinosis is associated with ischemic manifestations and increased disability in patients with systemic sclerosisAntonia Valenzuela, Murray Baron, Tatiana S Rodriguez-Reyna, et al.
Journal of Health Psychology|January 31, 2026
Development and initial validation of a brief measure of uncertainty in rheumatic diseaseCaleb Bolden, Lucy Finkelstein-Fox, April Jorge, et al.
Clinical Rheumatology|November 1, 2019
Collaborative National Quality and Efficacy Registry (CONQUER) for Scleroderma: outcomes from a multicenter US-based systemic sclerosis registryVictoria K Shanmugam, Tracy M Frech, Virginia D Steen, et al.
Seminars in Arthritis and Rheumatism|July 2, 2026
Autoantibody associations in patients with early diffuse cutaneous systemic sclerosis: the prospective registry of early systemic sclerosisAradhna Agarwal, Dahlia Hassan, Suiyuan Huang, et al.
ACR Open Rheumatology|April 23, 2022
Computed Tomography of the Chest to Screen for Interstitial Lung Disease in Patients With Systemic Sclerosis at Expert Scleroderma Centers in the United StatesElana J Bernstein, Shervin Assassi, Flavia V Castelino, et al.
Pageof 5

Showing results (21-30 of 50) with videos related to

Sort By:
Pageof 5
Seminars in Arthritis and Rheumatism|February 20, 2022
Change in calcinosis over 1 year using the scleroderma clinical trials consortium radiologic scoring system for calcinosis of the hands in patients with systemic sclerosisAntonia Valenzuela, Kathryn Stevens, Melody P Chung, et al.
Arthritis Care & Research|February 25, 2015
Barriers to and Facilitators of a Career as a Physician-Scientist Among Rheumatologists in the USAlexis Ogdie, Ami A Shah, Una E Makris, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|March 24, 2016
Autotaxin activity increases locally following lung injury, but is not required for pulmonary lysophosphatidic acid production or fibrosisKatharine E Black, Evgeny Berdyshev, Gretchen Bain, et al.
The Journal of Allergy and Clinical Immunology|March 15, 2016
Clonal expansion of CD4(+) cytotoxic T lymphocytes in patients with IgG4-related diseaseHamid Mattoo, Vinay S Mahajan, Takashi Maehara, et al.
Rheumatology (Oxford, England)|March 15, 2025
Belumosudil in diffuse cutaneous systemic sclerosis: a randomised, double-blind, open-label extension, placebo-controlled, Phase 2 studyLorinda Chung, Richard M Silver, Virginia Steen, et al.
Seminars in Arthritis and Rheumatism|September 8, 2020
Calcinosis is associated with ischemic manifestations and increased disability in patients with systemic sclerosisAntonia Valenzuela, Murray Baron, Tatiana S Rodriguez-Reyna, et al.
Journal of Health Psychology|January 31, 2026
Development and initial validation of a brief measure of uncertainty in rheumatic diseaseCaleb Bolden, Lucy Finkelstein-Fox, April Jorge, et al.
Clinical Rheumatology|November 1, 2019
Collaborative National Quality and Efficacy Registry (CONQUER) for Scleroderma: outcomes from a multicenter US-based systemic sclerosis registryVictoria K Shanmugam, Tracy M Frech, Virginia D Steen, et al.
Seminars in Arthritis and Rheumatism|July 2, 2026
Autoantibody associations in patients with early diffuse cutaneous systemic sclerosis: the prospective registry of early systemic sclerosisAradhna Agarwal, Dahlia Hassan, Suiyuan Huang, et al.
ACR Open Rheumatology|April 23, 2022
Computed Tomography of the Chest to Screen for Interstitial Lung Disease in Patients With Systemic Sclerosis at Expert Scleroderma Centers in the United StatesElana J Bernstein, Shervin Assassi, Flavia V Castelino, et al.
Pageof 5